SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)-- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced positive ...
Below are 3 natural substitutes to Bydureon that can reduce body weight and control blood sugar levels. For best results it is possible to use in a stack – this means combining 2 or more products ...
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) , Eli Lilly and Company (NYSE: LLY) and ...
Our study demonstrates reduction in postprandial glucose after exenatide injection in adolescents with type 1 diabetes. These effects were associated with delayed gastric emptying, and the results are ...
A convenient, once-weekly injection of exenatide in patients with type 2 diabetes was more effective at improving blood sugar control and inducing weight loss than were either daily oral sitagliptin ...
The type 2 diabetes drug exenatide (Bydureon, Byetta, AstraZeneca) has potential disease-modifying effects in Parkinson's disease, results of a randomized, double-blind, placebo-controlled trial ...
TORONTO, June 19, 2020 (GLOBE NEWSWIRE) -- New real-world data showed Trulicity® (dulaglutide) had significantly higher adherence and longer persistence compared to weekly injections of semaglutide or ...
The 121-patient, phase 2 study assessed the efficacy, safety and tolerability of three different doses of exenatide once monthly. It also assessed exenatide once weekly (exenatide extended-release for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results